Sienna rises after pricing $65M IPO

Dermatology company Sienna Biopharmaceuticals Inc. (NASDAQ:SNNA) gained $4.25 (28%) to $19.25 on Thursday after raising $65 million through the sale of 4.3 million shares at $15 in an IPO on NASDAQ underwritten by JPMorgan, Cowen and BMO Capital Markets. The price was at the midpoint of Sienna’s proposed range and values the company at $298.3 million. Sienna announced the news after market hours on Wednesday...